Related Experiment Videos
Cyclosporine-induced folliculodystrophy.
Michael R Heaphy1, H Nicholas Shamma, Martha Hickmann
1Division of Dermatology, Wright State University School of Medicine, Dayton, Ohio 45402, USA. mheaphy@ureach.com
Journal of the American Academy of Dermatology
|January 17, 2004
Summary
A kidney transplant patient experienced a unique skin reaction, cyclosporine induced folliculodystrophy (CIF), characterized by papules on the face and body. This condition is linked to cyclosporine immunosuppression.
Area of Science:
- Dermatology
- Nephrology
- Immunology
Background:
- Cyclosporine is a vital immunosuppressant medication used in organ transplantation.
- Cutaneous side effects of immunosuppressants can impact patient quality of life and treatment adherence.
Observation:
- A 34-year-old kidney transplant recipient presented with a distinct skin condition.
- The condition manifested as infiltrated skin with numerous flesh-colored, follicular papules primarily on the face (ears, nose) but also on the trunk and extremities.
Findings:
- The patient's clinical and histological presentation aligns with two prior reported cases.
- Cyclosporine, at immunosuppressive doses, is implicated as the causative agent.
- The study details unique clinicohistopathologic findings and proposes a pathogenic theory based on in vitro cyclosporine studies.
Implications:
- The proposed term 'cyclosporine induced folliculodystrophy' (CIF) defines this distinct clinicohistopathologic entity.
- Diagnostic criteria (3 clinical, 4 histopathologic) are established for CIF.
- Understanding CIF is crucial for managing cyclosporine-treated transplant patients and their dermatological health.